Pharma & Biotech

The acquisition of Walgreens Boots Alliance by Sycamore Partners has been finalized, marking a significant turning point for the major...

The investment thesis for medical technology firm Cytosorbents hinges on a single, pending regulatory milestone. With its innovative DrugSorb-ATR blood...

Medical technology company ClearPoint Neuro has secured a significant regulatory expansion for its Neuro-Laser Therapy System. The latest FDA clearance...

BioNTech SE has achieved a significant milestone in its oncology pipeline, with a novel breast cancer therapy demonstrating superior results...

In a major strategic move, healthcare distributor Cardinal Health is making a nearly $2 billion wager to accelerate its growth...

Immunovant Inc. has jolted the biotechnology sector with compelling long-term results for its lead drug candidate, batoclimab, in treating Graves'...

Eli Lilly has gained significant competitive advantage in the development of innovative cancer therapies following a crucial regulatory decision by...

Assembly Biosciences' stock remains entrenched in a pronounced bearish phase, with investor sentiment staying decidedly negative despite recent corporate developments....

As markets resumed activity following the extended holiday weekend, Protara Therapeutics presented investors with a complex financial picture. The company...

The company formerly known as IsoRay has undergone a significant transformation. Following its merger with Viewpoint Molecular Targeting, the entity...